Published by Josh White on 16th January 2026
(Sharecast News) - CelLBxHealth said in an update on Friday that it expected to report lower-than-anticipated revenues for 2025 after the deferral of several sales contracts, while highlighting a strong cash position and significant cost reductions as it positions the business for commercial progress in 2026.